{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:34Z","timestamp":1793050594664,"version":"4.5.0"},"reference-count":84,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"DOI":"10.1001\/jamadermatol.2021.1463","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T18:21:43Z","timestamp":1622053303000},"source":"Crossref","is-referenced-by-count":28,"title":["A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis"],"prefix":"10.1001","author":[{"given":"Michael","family":"Hughes","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"El Aoufy","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Division of Rheumatology AOUC, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre of Rheumatology, Royal Free Hospital, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Scleroderma Program, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Krieg","sequence":"additional","affiliation":[{"name":"Translational Matrix Biology and Department for Dermatology, Medical Faculty, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Division of Rheumatology AOUC, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"drv210002r1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis.","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"10103","key":"drv210002r2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis.","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"drv210002r3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"drv210002r4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41584-020-0386-4","article-title":"Raynaud phenomenon and digital ulcers in systemic sclerosis.","volume":"16","author":"Hughes","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"drv210002r5","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"issue":"1","key":"drv210002r6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","article-title":"Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis.","volume":"54","author":"Bruni","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"drv210002r7","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","article-title":"Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.","volume":"49","author":"Amanzi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"drv210002r8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13075-019-1822-1","article-title":"Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher\/European Scleroderma Trials and Research group (EUSTAR) survey.","volume":"21","author":"Blagojevic","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"drv210002r9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/acr.v63.2","article-title":"Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers.","volume":"63","author":"B\u00e9rezn\u00e9","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"drv210002r10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/acr.v72.5","article-title":"Multicenter qualitative study exploring the patient experience of digital ulcers in systemic sclerosis.","volume":"72","author":"Hughes","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"drv210002r11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13075-019-2080-y","article-title":"Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden.","volume":"21","author":"Morrisroe","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"drv210002r12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037568","article-title":"What narrative devices do people with systemic sclerosis use to describe the experience of pain from digital ulcers: a multicentre focus group study at UK scleroderma centres.","volume":"10","author":"Jones","year":"2020","journal-title":"BMJ Open"},{"issue":"8","key":"drv210002r13","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/rheumatology\/keaa037","article-title":"Patient experiences of digital ulcer development and evolution in systemic sclerosis.","volume":"59","author":"Hughes","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"drv210002r14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","article-title":"Digital ulcers in systemic sclerosis.","volume":"56","author":"Hughes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"drv210002r15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","article-title":"Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study.","volume":"71","author":"Smith","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"drv210002r16","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/art.v68.10","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study.","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"drv210002r17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/03009742.2016.1178802","article-title":"Digital ulcers in systemic sclerosis are associated with microangiopathic abnormalities of perilesional skin as assessed by capillaroscopy.","volume":"46","author":"Hughes","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"drv210002r18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mehy.2018.04.024","article-title":"Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?","volume":"116","author":"Hughes","year":"2018","journal-title":"Med Hypotheses"},{"issue":"7","key":"drv210002r19","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3899\/jrheum.081044","article-title":"Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (Itin\u00e9rAIR-Scl\u00e9rodermie).","volume":"36","author":"Tiev","year":"2009","journal-title":"J Rheumatol"},{"issue":"1","key":"drv210002r20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"drv210002r21","first-page":"218","article-title":"A pilot study using high-frequency ultrasound to measure digital ulcers: a possible outcome measure in systemic sclerosis clinical trials?","volume":"35","author":"Hughes","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"drv210002r22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/jsrd.5000238","article-title":"The critical need for accurately defining digital ulcers in scleroderma.","volume":"2","author":"Li","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"drv210002r23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5301\/jsrd.5000236","article-title":"Defining skin ulcers in systemic sclerosis: systematic literature review and proposed World Scleroderma Foundation (WSF) definition.","volume":"2","author":"Suliman","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"drv210002r24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/2397198318764796","article-title":"Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: a challenge for clinical trial design.","volume":"3","author":"Hughes","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"10","key":"drv210002r25","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry.","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"s1","key":"drv210002r26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1046\/j.1524-475X.11.s2.1.x","article-title":"Wound bed preparation: a systematic approach to wound management.","volume":"11","author":"Schultz","year":"2003","journal-title":"Wound Repair Regen"},{"issue":"1","key":"drv210002r27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/ard.59.1.39","article-title":"Macrovascular disease and systemic sclerosis.","volume":"59","author":"Ho","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"drv210002r28","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/annrheumdis-2017-212829","article-title":"Tracking digital ulcers in systemic sclerosis: a feasibility study assessing lesion area in patient-recorded smartphone photographs.","volume":"77","author":"Dinsdale","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"drv210002r29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/acr.v70.3","article-title":"Quantifying digital ulcers in systemic sclerosis: reliability of computer-assisted planimetry in measuring lesion size.","volume":"70","author":"Simpson","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"drv210002r30","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s10067-018-3986-5","article-title":"Ultrasound characterization of cutaneous ulcers in systemic sclerosis.","volume":"37","author":"Suliman","year":"2018","journal-title":"Clin Rheumatol"},{"key":"drv210002r31","article-title":"The role of ultrasound in systemic sclerosis: on the cutting edge to foster clinical and research advancement.","author":"Hughes","journal-title":"J Scleroderma Relat Disord."},{"key":"drv210002r32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mvr.2015.06.009","article-title":"Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients.","volume":"101","author":"Ruaro","year":"2015","journal-title":"Microvasc Res"},{"issue":"3","key":"drv210002r33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4081\/reumatismo.2017.986","article-title":"Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis.","volume":"69","author":"Ruaro","year":"2017","journal-title":"Reumatismo"},{"issue":"8","key":"drv210002r34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3899\/jrheum.151412","article-title":"Thermographic abnormalities are associated with future digital ulcers and death in patients with systemic sclerosis.","volume":"43","author":"Hughes","year":"2016","journal-title":"J Rheumatol"},{"issue":"6","key":"drv210002r35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3899\/jrheum.171486","article-title":"Preliminary validation of the digital ulcer clinical assessment score in systemic sclerosis.","volume":"46","author":"Bruni","year":"2019","journal-title":"J Rheumatol"},{"issue":"1","key":"drv210002r36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/msc.v18.1","article-title":"Improving access to digital ulcer care through nurse-led clinic: a service evaluation.","volume":"18","author":"Ngcozana","year":"2020","journal-title":"Musculoskeletal Care"},{"issue":"11","key":"drv210002r37","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"drv210002r38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10067-013-2460-7","article-title":"Consensus opinion of a North American working group regarding the classification of digital ulcers in systemic sclerosis.","volume":"33","author":"Baron","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"5","key":"drv210002r39","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/S2665-9913(19)30164-X","article-title":"Digital ulcers: should debridement be a standard of care in systemic sclerosis?","volume":"2","author":"Hughes","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"drv210002r40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5301\/jsrd.5000268","article-title":"Review of local wound management for scleroderma-associated digital ulcers.","volume":"3","author":"Lebedoff","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"drv210002r41","first-page":"5","article-title":"Procedural pain management in the treatment of scleroderma digital ulcers.","volume":"33","author":"Giuggioli","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"drv210002r42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10067-019-04924-4","article-title":"Digital ulcer debridement in systemic sclerosis: a systematic literature review.","volume":"39","author":"Hughes","year":"2020","journal-title":"Clin Rheumatol"},{"key":"drv210002r43","article-title":"Hand osteomyelitis in patients with secondary Raynaud phenomenon.","author":"Haque","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"drv210002r44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens.","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6673","key":"drv210002r45","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/bmj.298.6673.561","article-title":"Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud\u2019s phenomenon in patients with systemic sclerosis: a double blind randomised study.","volume":"298","author":"Rademaker","year":"1989","journal-title":"BMJ"},{"issue":"9","key":"drv210002r46","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acr.22018","article-title":"Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis.","volume":"65","author":"Tingey","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"drv210002r47","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","article-title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.","volume":"75","author":"Hachulla","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"drv210002r48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","article-title":"Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.","volume":"120","author":"Wigley","year":"1994","journal-title":"Ann Intern Med"},{"issue":"3","key":"drv210002r49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10238-019-00553-y","article-title":"Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study.","volume":"19","author":"Negrini","year":"2019","journal-title":"Clin Exp Med"},{"issue":"5","key":"drv210002r50","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s10067-018-4043-0","article-title":"The safety of iloprost in systemic sclerosis in a real-life experience.","volume":"37","author":"Bellando-Randone","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"12","key":"drv210002r51","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/art.40242","article-title":"Efficacy and safety of selexipag in adults with Raynaud\u2019s phenomenon secondary to systemic sclerosis: a randomized, placebo-controlled, phase ii study.","volume":"69","author":"Denton","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"drv210002r52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5301\/jsrd.5000232","article-title":"Digital ulcers in SSc treated with oral treprostinil: a randomized, double-blind, placebo-controlled study with open-label follow-up.","volume":"2","author":"Seibold","year":"2017","journal-title":"J Scleroderma Relat Disord."},{"issue":"12","key":"drv210002r53","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"drv210002r54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"drv210002r55","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1001\/jama.2016.5258","article-title":"Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials.","volume":"315","author":"Khanna","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"drv210002r56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaad.2014.04.028","article-title":"Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: results of a prospective pilot study.","volume":"71","author":"Chung","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"drv210002r57","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/bjd.1990.122.issue-5","article-title":"Cyclosporin A treatment of systemic sclerosis.","volume":"122","author":"Zachariae","year":"1990","journal-title":"Br J Dermatol"},{"issue":"7","key":"drv210002r58","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10067-014-2579-1","article-title":"Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.","volume":"33","author":"Khor","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"drv210002r59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/rheumatology\/keu435","article-title":"Treatment of systemic sclerosis with tocilizumab.","volume":"54","author":"Fernandes das Neves","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"drv210002r60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2340\/00015555-1678","article-title":"Effective oral psoralen plus ultraviolet a therapy for digital ulcers with revascularization in systemic sclerosis.","volume":"94","author":"Inoue","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"drv210002r61","first-page":"51","article-title":"Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis.","volume":"27","author":"Fiori","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"drv210002r62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mvr.2016.12.008","article-title":"Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate.","volume":"111","author":"Hughes","year":"2017","journal-title":"Microvasc Res"},{"issue":"3","key":"drv210002r63","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/09546634.2018.1484875","article-title":"A feasibility study of a novel low-level light therapy for digital ulcers in systemic sclerosis.","volume":"30","author":"Hughes","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"11","key":"drv210002r64","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3727\/096368914X685636","article-title":"Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis.","volume":"24","author":"Del Papa","year":"2015","journal-title":"Cell Transplant"},{"issue":"1","key":"drv210002r65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-018-1792-8","article-title":"Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study.","volume":"21","author":"Del Papa","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"drv210002r66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/s10165-010-0274-x","article-title":"Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow\u2013derived cells.","volume":"20","author":"Ishigatsubo","year":"2010","journal-title":"Mod Rheumatol"},{"issue":"1","key":"drv210002r67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","article-title":"Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis.","volume":"48","author":"Nevskaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"drv210002r68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.retram.2016.10.006","article-title":"Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients.","volume":"65","author":"Daumas","year":"2017","journal-title":"Curr Res Transl Med"},{"issue":"10","key":"drv210002r69","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"issue":"5","key":"drv210002r70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10067-012-2161-7","article-title":"Osteomyelitis complicating scleroderma digital ulcers.","volume":"32","author":"Giuggioli","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"9","key":"drv210002r71","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s10067-020-05128-x","article-title":"Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis.","volume":"39","author":"Haque","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"8","key":"drv210002r72","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis.","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"drv210002r73","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis.","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"drv210002r74","first-page":"888","article-title":"Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.","volume":"7","author":"Ambach","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"drv210002r75","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/j.jaad.2011.04.029","article-title":"Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.","volume":"65","author":"Moinzadeh","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"drv210002r76","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.semarthrit.2015.10.013","article-title":"A review of the effects of statins in systemic sclerosis.","volume":"45","author":"Ladak","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"drv210002r77","first-page":"1801","article-title":"Statins: potentially useful in therapy of systemic sclerosis-related Raynaud\u2019s phenomenon and digital ulcers.","volume":"35","author":"Abou-Raya","year":"2008","journal-title":"J Rheumatol"},{"issue":"10","key":"drv210002r78","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Trial of platelet-inhibiting drug in scleroderma: double-blind study with dipyridamole and aspirin.","volume":"27","author":"Beckett","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"drv210002r79","first-page":"499","article-title":"Long-term low molecular weight heparin therapy for severe Raynaud\u2019s phenomenon: a pilot study.","volume":"18","author":"Denton","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"drv210002r80","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/micr.v35.6","article-title":"Surgical treatment of systemic sclerosis\u2014is it justified to offer peripheral sympathectomy earlier in the disease process?","volume":"35","author":"Momeni","year":"2015","journal-title":"Microsurgery"},{"issue":"6","key":"drv210002r81","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/SAP.0000000000000614","article-title":"Digital sympathectomy in patients with scleroderma: an overview of the practice and referral patterns and perceptions of rheumatologists.","volume":"75","author":"Chiou","year":"2015","journal-title":"Ann Plast Surg"},{"issue":"2","key":"drv210002r82","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/2397198319863565","article-title":"Microvascular hand surgery for digital ischemia in scleroderma.","volume":"5","author":"Satteson","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"drv210002r83","doi-asserted-by":"publisher","first-page":"864","DOI":"10.5114\/aoms.2015.48152","article-title":"Botulinum toxin A in the treatment of Raynaud\u2019s phenomenon: a systematic review.","volume":"12","author":"Zebryk","year":"2016","journal-title":"Arch Med Sci"},{"issue":"1","key":"drv210002r84","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1346-8138.13030","article-title":"Beneficial effect of botulinum toxin A on Raynaud\u2019s phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study.","volume":"43","author":"Motegi","year":"2016","journal-title":"J Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2780048\/jamadermatology_hughes_2021_rv_210002_1620746576.7067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T18:21:59Z","timestamp":1622053319000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2780048"}},"subtitle":["A Narrative Review"],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":84,"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.1463","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,26]]}}}